-
M.
Niemi,
M.
Pasanen,
P.
Neuvonen
(2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Pharmacological Reviews, 63
-
M.
Soars,
P.
Barton,
M.
Ismair,
Rachael
Jupp,
R.
Riley
(2012)
The Development, Characterization, and Application of an OATP1B1 Inhibition Assay in Drug Discovery
Drug Metabolism and Disposition, 40
-
A.
Rodrigues,
G.
Winchell,
M.
Dobrinska
(2001)
Use of In Vitro Drug Metabolism Data to Evaluate Metabolic Drug‐Drug Interactions in Man: The Need for Quantitative Databases
The Journal of Clinical Pharmacology, 41
-
J.
Mehta,
I.
Gandhi,
S.
Sane,
M.
Wamburkar
(1985)
Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Indian journal of leprosy, 57 2
-
W.
Lemahieu,
M.
Hermann,
A.
Åsberg,
K.
Verbeke,
H.
Holdaas,
Y.
Vanrenterghem,
B.
Maes
(2005)
Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus
American Journal of Transplantation, 5
-
G.
Acocella,
R.
Conti,
M.
Luisetti,
E.
Pozzi,
C.
Grassi
(1985)
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study.
The American review of respiratory disease, 132 3
-
Paul
Martin,
M.
Warwick,
A.
Dane,
C.
Brindley,
Tracy
Short
(2003)
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
Clinical therapeutics, 25 10
-
T.
Prueksaritanont,
Yuhsin
Kuo,
Cuyue
Tang,
Chunze
Li,
Y.
Qiu,
B.
Lu,
Kristie
Strong-Basalyga,
K.
Richards,
B.
Carr,
J.
Lin
(2006)
In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies
Drug Metabolism and Disposition, 34
-
Hong
Shen,
F.
Lee,
J.
Gan
(2011)
Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2)
Journal of Pharmacology and Experimental Therapeutics, 337
-
Olena
Kis,
Jason
Zastre,
M.
Ramaswamy,
R.
Bendayan
(2010)
pH Dependence of Organic Anion-Transporting Polypeptide 2B1 in Caco-2 Cells: Potential Role in Antiretroviral Drug Oral Bioavailability and Drug–Drug Interactions
Journal of Pharmacology and Experimental Therapeutics, 334
-
Laura
Hinton,
A.
Galetin,
J.
Houston
(2008)
Multiple Inhibition Mechanisms and Prediction of Drug–Drug Interactions: Status of Metabolism and Transporter Models as Exemplified by Gemfibrozil–Drug Interactions
Pharmaceutical Research, 25
-
J.
Noé,
Renée
Portmann,
Marie-Elise
Brun,
C.
Funk
(2007)
Substrate-Dependent Drug-Drug Interactions between Gemfibrozil, Fluvastatin and Other Organic Anion-Transporting Peptide (OATP) Substrates on OATP1B1, OATP2B1, and OATP1B3
Drug Metabolism and Disposition, 35
-
(2005)
Prescribing information on Rafadin ( Rifampin ) , in Physicians ’ Desk Reference
-
T.
Akabane,
K.
Tabata,
K.
Kadono,
S.
Sakuda,
S.
Terashita,
T.
Teramura
(2010)
A Comparison of Pharmacokinetics between Humans and Monkeys
Drug Metabolism and Disposition, 38
-
H.
Satoh,
F.
Yamashita,
M.
Tsujimoto,
H.
Murakami,
N.
Koyabu,
H.
Ohtani,
Y.
Sawada
(2005)
CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B
Drug Metabolism and Disposition, 33
-
C.
Gui,
A.
Obaidat,
R.
Chaguturu,
B.
Hagenbuch
(2010)
Development of a Cell-Based High-Throughput Assay to Screen for Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3
Current Chemical Genomics, 4
-
Yong‐Hae
Han,
D.
Busler,
Yang
Hong,
Yuan
Tian,
Cliff
Chen,
A.
Rodrigues
(2010)
Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Liver Drug Transporters
Drug Metabolism and Disposition, 38
-
Yong‐Hae
Han,
D.
Busler,
Yang
Hong,
Yuan
Tian,
Cliff
Chen,
A.
Rodrigues
(2010)
Transporter Studies with the 3-O-Sulfate Conjugate of 17α-Ethinylestradiol: Assessment of Human Kidney Drug Transporters
Drug Metabolism and Disposition, 38
-
G.
Acocella
(1978)
Clinical Pharmacokinetics of Rifampicin
Clinical Pharmacokinetics, 3
-
K.
Giacomini,
Shiew-Mei
Huang,
D.
Tweedie,
L.
Benet,
K.
Brouwer,
X.
Chu,
A.
Dahlin,
R.
Evers,
V.
Fischer,
K.
Hillgren,
K.
Hoffmaster,
T.
Ishikawa,
D.
Keppler,
R.
Kim,
Caroline
Lee,
M.
Niemi,
J.
Polli,
Y.
Sugiyama,
P.
Swaan,
J.
Ware,
S.
Wright,
S.
Yee,
M.
Zamek-Gliszczynski,
Lei
Zhang
(2010)
Membrane transporters in drug development
Nature Reviews Drug Discovery, 9
-
Y.
Shirasaka,
Takanori
Mori,
Megumi
Shichiri,
T.
Nakanishi,
I.
Tamai
(2012)
Functional pleiotropy of organic anion transporting polypeptide OATP2B1 due to multiple binding sites.
Drug metabolism and pharmacokinetics, 27 3
-
(2006)
Cloning and characterization of cynomolgus monkey and rhesus monkey organic anion transporting poloypeptide 1B3 and comparison of their function with human OATP-1B3
-
A.
Mazzu,
K.
Lasseter,
E.
Shamblen,
V.
Agarwal,
J.
Lettieri,
Pavur
Sundaresen
(2000)
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin
Clinical Pharmacology & Therapeutics, 68
-
Paul
Martin,
M.
Warwick,
A.
Dane,
M.
Cantarini
(2003)
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.
Clinical therapeutics, 25 8
-
K.
Fenner,
H.
Jones,
M.
Ullah,
S.
Kempshall,
M.
Dickins,
Yurong
Lai,
P.
Morgan,
H.
Barton
(2012)
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance
Xenobiotica, 42
-
S.
Kitamura,
K.
Maeda,
Yi
Wang,
Y.
Sugiyama
(2008)
Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin
Drug Metabolism and Disposition, 36
-
Masa
Yasunaga,
M.
Takemura,
Kyoko
Fujita,
H.
Yabuuchi,
M.
Wada
(2008)
Molecular cloning and functional characterization of cynomolgus monkey multidrug resistance-associated protein 2 (MRP2).
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 35 4
-
Kelvin
Cooper,
Paul
Martin,
A.
Dane,
M.
Warwick,
D.
Schneck,
M.
Cantarini
(2003)
Effect of itraconazole on the pharmacokinetics of rosuvastatin
Clinical Pharmacology & Therapeutics, 73
-
Y.
Yabe,
A.
Galetin,
J.
Houston
(2011)
Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
Drug Metabolism and Disposition, 39
-
G.
Acocella
(1986)
PHARMACOKINETIC STUDIES ON ANTITUBERCULOSIS REGIMENS IN HYMANS
Pediatric Infectious Disease Journal, 5
-
R.
Vuppugalla,
Sean
Kim,
T.
Zvyaga,
Yong‐Hae
Han,
P.
Balimane,
P.
Marathe,
A.
Rodrigues
(2010)
Anticipating and Minimizing Drug Interactions in a Drug Discovery and Development Setting: An Industrial Perspective
-
Paul
Martin,
M.
Warwick,
A.
Dane,
S.
Hill,
P.
Giles,
P.
Phillips,
E.
Lenz
(2003)
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.
Clinical therapeutics, 25 11
-
Nan
Li,
Weifang
Hong,
Hong
Huang,
Hanping
Lu,
Guangyun
Lin,
Mei
Hong
(2012)
Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1
PLoS ONE, 7
-
Wei
Zhang,
S.
Deng,
Xiaoping
Chen,
Gan
Zhou,
H.
Xie,
F-Y
He,
D.
Cao,
Yuan‐jian
Li,
Honghao
Zhou
(2008)
Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.
Clinical therapeutics, 30 7
-
M.
Ebeling,
Erich
Küng,
A.
See,
C.
Broger,
Guido
Steiner,
M.
Berrera,
Tobias
Heckel,
L.
Iniguez,
T.
Albert,
R.
Schmucki,
Hermann
Biller,
T.
Singer,
U.
Certa
(2011)
Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment.
Genome research, 21 10
-
Cuyue
Tang,
T.
Prueksaritanont
(2010)
Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions
Pharmaceutical Research, 27
-
A.
Koenen,
K.
Köck,
M.
Keiser,
W.
Siegmund,
H.
Kroemer,
M.
Grube
(2012)
Steroid hormones specifically modify the activity of organic anion transporting polypeptides.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 47 4
-
M.
Hirano,
K.
Maeda,
Y.
Shitara,
Y.
Sugiyama
(2006)
DRUG-DRUG INTERACTION BETWEEN PITAVASTATIN AND VARIOUS DRUGS VIA OATP1B1
Drug Metabolism and Disposition, 34
-
K.
Iwasaki,
Y.
Uno
(2009)
Cynomolgus monkey CYPs: a comparison with human CYPs
Xenobiotica, 39
-
(2010)
Comparison of the function of transporters involved in the hepatic and renal uptake of drugs between monkeys and humans. The 130th
-
M.
Karlgren,
Gustav
Ahlin,
Christel
Bergström,
R.
Svensson,
J.
Palm,
P.
Artursson
(2011)
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
Pharmaceutical Research, 29
-
Kenta
Yoshida,
K.
Maeda,
Yuichi
Sugiyama
(2012)
Transporter‐Mediated Drug–Drug Interactions Involving OATP Substrates: Predictions Based on In Vitro Inhibition Studies
Clinical Pharmacology & Therapeutics, 91
-
Harunobu
Tahara,
Masayuki
Shono,
H.
Kusuhara,
H.
Kinoshita,
E.
Fuse,
A.
Takadate,
M.
Otagiri,
Y.
Sugiyama
(2005)
Molecular Cloning and Functional Analyses of OAT1 and OAT3 from Cynomolgus Monkey Kidney
Pharmaceutical Research, 22
-
M.
Hirano,
K.
Maeda,
Y.
Shitara,
Y.
Sugiyama
(2004)
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Journal of Pharmacology and Experimental Therapeutics, 311
-
Y.
Imamura,
N.
Murayama,
N.
Okudaira,
Atsushi
Kurihara,
Osamu
Okazaki,
Takashi
Izumi,
Katsuhisa
Inoue,
Hiroaki
Yuasa,
H.
Kusuhara,
Yuichi
Sugiyama
(2011)
Prediction of Fluoroquinolone‐Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion
Clinical Pharmacology & Therapeutics, 89